Meeting
2020 Gastrointestinal Cancers Symposium
Significance of intratumoral tertiary lymphoid structure (TLS) as predictictive factors of nivolumab therapy after conversion surgery for unresectable gastric cancer: A retrospective study.
Authors
Hiroaki Tanaka
Department of Gastroenterological Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan
Hiroaki Tanaka , Takuya Mori , Kenjiro Kimura , Kazuya Muguruma , Kosei Hirakawa , Masaichi Ohira
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Esophageal and Gastric Cancer and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Translational Research
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 412)
Abstract #
412
Poster Bd #
G1
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Advantages of robotic surgery for advanced gastric cancer in short-term outcomes: A single-center retrospective study using propensity score matching.
First Author: Masaru Komatsu
Poster
2024 ASCO Gastrointestinal Cancers Symposium
A scoring system for selecting nivolumab or irinotecan in the later-line chemotherapy for advanced gastric cancer: A Japanese multicenter retrospective study.
First Author: Yusuke Amanuma
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Efficacy and safety of trastuzumab deruxtecan and nivolumab as third- or later-line treatment for HER2-positive advanced gastric cancer: A single-institution retrospective study.
First Author: Keitaro Shimozaki
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Association of disease progression pattern during third-line chemotherapy with nivolumab with poor prognosis in advanced gastric cancer: A multicenter retrospective study in Japan.
First Author: Shigenori Kadowaki